Kazuhiro Tanaka

19PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapySolid tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 26, 2025
Methotrexate, Doxorubicin, and Cisplatin Versus Methotrexate, Doxorubicin, and Cisplatin + Ifosfamide in Poor Responders to Preoperative Chemotherapy for Newly Diagnosed High-Grade Osteosarcoma (JCOG0905): A Multicenter, Open-Label, Randomized Trial.

Hiroaki Hiraga, Ryunosuke Machida, Akira Kawai

|Feb 07, 2025
Clinicopathological background of local recurrence in high grade sarcoma of the extremity with preoperative chemotherapy: a supplementary analysis of JCOG0304.

Satoshi Tsukushi, Kazuhiro Tanaka, Toshiyuki Kunisada

|Feb 03, 2025
Current management of neurotrophic receptor tyrosine kinase fusion-positive sarcoma: an updated review.

Yuta Kubota, Masanori Kawano, Tatsuya Iwasaki

|Nov 05, 2024
Study protocol: randomized phase III trial of neo-adjuvant and adjuvant chemotherapy vs. immediate surgery and adjuvant chemotherapy for localized soft tissue sarcoma: Japan Clinical Oncology Group study JCOG2102 (NACLESS).

Yuki Funauchi, Satoshi Tsukushi, Hiroaki Hiraga

|Feb 23, 2024
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.

Shintaro Sugita, Kazuhiro Tanaka, Yoshinao Oda

|Dec 08, 2023
Sequential treatments with TRK inhibitors in a patient with NTRK fusion-positive sarcoma: A case report.

Yuta Kubota, Masanori Kawano, Tatsuya Iwasaki

Pageof 4

Frequent Collaborators

5 joint publications

Toshiyuki Kunisada

3 joint publications

Akihito Nagano

3 joint publications

Yoshihiro Nishida

3 joint publications

Makoto Endo